A C Videler1, G Rossi2, M Schoevaars3, C M van der Feltz-Cornelis4, C van der Feltz, S P J van Alphen2. 1. Breburg Hospital,Department of Old Age Psychiatry,Tilburg,the Netherlands. 2. Department of Clinical & Life Span Psychology,Vrije Universiteit Brussel (VUB),Brussels,Belgium. 3. Psychology Practice Schoevaars,Capelle aan den IJssel,the Netherlands. 4. Tilburg University,Tranzo Department,Tilburg,the Netherlands.
Abstract
BACKGROUND:Short-term group schema cognitive behavior therapy (SCBT-g) showed improvements in overall symptomatology, early maladaptive schemas (EMS) and schema modes, both in adults and adolescents with personality disorder (PD) features and long-standing mood disorders. However, no research has yet been carried out on the effect in older adults. Therefore, in a proof of concept study, we explored the effect of SCBT-g in older outpatients with PD features and longstanding mood disorders. METHOD: Thirty-one older outpatients, aged 60-78 years with PD featuresand/or longstanding mood disorders were included in a proof of concept study with pre-mid-post design. Primary outcome was psychological distress (Brief Symptom Inventory) and intermediate outcomes were EMS (Young Schema Questionnaire) and schema modes (Schema Mode Inventory), assessed at baseline, mid-treatment and end-of-treatment. Paired samples t-tests were conducted, and Cohen's d effect sizes reported for pre mid- and post-treatment. As proof of concept analysis, hierarchical regression analyses with residual change scores were used to analyse whether early process changes in EMS (intermediate outcomes) predicted later outcome changes in symptoms. RESULTS:SCBT-g led to significant improvement in all three measures of psychological symptoms, EMS and modes with medium effect sizes. Pre-treatment to mid-treatment changes in schema severity predicted symptom improvement from mid- to end-of-treatment. CONCLUSION: This proof of concept study shows that SCBT-g has potential to change EMS and to show significant effect at symptom level in older outpatients with PD features. A control condition in a randomized controlled trial is a necessary step for further research.
RCT Entities:
BACKGROUND: Short-term group schema cognitive behavior therapy (SCBT-g) showed improvements in overall symptomatology, early maladaptive schemas (EMS) and schema modes, both in adults and adolescents with personality disorder (PD) features and long-standing mood disorders. However, no research has yet been carried out on the effect in older adults. Therefore, in a proof of concept study, we explored the effect of SCBT-g in older outpatients with PD features and longstanding mood disorders. METHOD: Thirty-one older outpatients, aged 60-78 years with PD features and/or longstanding mood disorders were included in a proof of concept study with pre-mid-post design. Primary outcome was psychological distress (Brief Symptom Inventory) and intermediate outcomes were EMS (Young Schema Questionnaire) and schema modes (Schema Mode Inventory), assessed at baseline, mid-treatment and end-of-treatment. Paired samples t-tests were conducted, and Cohen's d effect sizes reported for pre mid- and post-treatment. As proof of concept analysis, hierarchical regression analyses with residual change scores were used to analyse whether early process changes in EMS (intermediate outcomes) predicted later outcome changes in symptoms. RESULTS:SCBT-g led to significant improvement in all three measures of psychological symptoms, EMS and modes with medium effect sizes. Pre-treatment to mid-treatment changes in schema severity predicted symptom improvement from mid- to end-of-treatment. CONCLUSION: This proof of concept study shows that SCBT-g has potential to change EMS and to show significant effect at symptom level in older outpatients with PD features. A control condition in a randomized controlled trial is a necessary step for further research.
Authors: S P J van Alphen; S D M van Dijk; A C Videler; G Rossi; E Dierckx; F Bouckaert; R C Oude Voshaar Journal: Curr Psychiatry Rep Date: 2015-01 Impact factor: 5.285
Authors: Krystle A P Penders; Inge G P Peeters; Job F M Metsemakers; Sebastiaan P J van Alphen Journal: Curr Psychiatry Rep Date: 2020-02-06 Impact factor: 5.285
Authors: S D M van Dijk; M S Veenstra; R Bouman; J Peekel; D H Veenstra; P J van Dalen; A D I van Asselt; M L Boshuisen; S P J van Alphen; R H S van den Brink; R C Oude Voshaar Journal: BMC Psychiatry Date: 2019-01-15 Impact factor: 3.630